Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein (Nasdaq: HSIC) reported Q2 2024 financial results with total net sales of $3.1 billion, up 1.1% from Q2 2023. GAAP diluted EPS was $0.80, while non-GAAP diluted EPS reached $1.23. The company updated its 2024 guidance, now expecting total sales growth of 4% to 6% and non-GAAP diluted EPS between $4.70 and $4.82. Henry Schein announced a new restructuring plan targeting $75-$100 million in annual run-rate savings and increased its share repurchase authorization by $500 million. The company reported strong operating cash flow of $296 million for Q2 and $493 million year-to-date, up $192 million compared to 2023.
Henry Schein (Nasdaq: HSIC) has released its 2023 CARES Report on Sustainability and Corporate Citizenship, highlighting progress in five key areas: health care access, policies and innovation, relationship-building, employee empowerment, and environmental sustainability. The company has:
- Committed to Net Zero by 2050
- Increased North American distribution recycling by 28.8%
- Expanded Diversity and Inclusion education
- Donated over $40 million to global charitable partners
- Increased board diversity
- Updated business standards and data protection principles
- Launched a Corporate Citizenship Barometer
CEO Stanley M. Bergman emphasized the company's 92-year history of corporate citizenship and its commitment to creating a sustainable, healthier future.
Henry Schein, the world's largest provider of healthcare solutions to office-based dental and medical practitioners, celebrated the opening of its new 811,000-square-foot Southwestern Distribution Center in Fort Worth, Texas. This facility is the largest in the company's global network and aims to enhance supply chain efficiency and customer service. The ribbon-cutting ceremony was attended by approximately 300 people, including company leaders, supplier partners, and elected officials. The center is 30% larger than Henry Schein's next biggest distribution site and houses 255 employees. The new facility replaces the 242,000-square-foot Grapevine, Texas center, with over 95% of Grapevine's staff relocating. This expansion reflects Henry Schein's commitment to innovation, reliability, and meeting customer needs.
Henry Schein (Nasdaq: HSIC) will release its second quarter 2024 financial results on August 6, 2024, before the stock market opens. The company, a leading provider of healthcare solutions for dental and medical practitioners, will also host a live webcast of its earnings conference call at 10:00 a.m. ET on the same day. Key speakers will include Stanley M. Bergman, Chairman and CEO, and Ronald N. South, Senior VP and CFO. The webcast can be accessed at the company's investor relations website, with a replay available post-event.
BioHorizons has introduced the Tapered Pro Conical, a dental implant featuring a deep conical connection designed to enhance surgical efficiency and provide immediate treatment options. This product is part of Henry Schein's broader strategy to invest in innovative technologies for clinical and workflow improvements. The Tapered Pro Conical incorporates the patented CONELOG® connection and Laser-Lok microchannels, which aid in connective tissue attachment and crestal bone retention. It is optimized for primary stability and includes self-tapping helical cutting flutes for controlled implant placement. The accompanying surgical kit supports both free hand and keyless guided approaches, enhancing surgical and restorative efficiency with just two prosthetic platforms.
The S.M.I.L.E. Healthcare Pathway Program, led by Henry Schein (NASDAQ: HSIC), the National Dental Association, and the Schattner Foundation, announced new partnerships to enhance its mission. Organizations joining include the Hispanic Dental Association, the Society of American Indian Dentists, Meharry Medical College School of Dentistry, and A.T. Still University's dental schools. The program aims to recruit students from underrepresented backgrounds into the dental profession through mentorship, hands-on learning, and career exposure. The 2024 session will occur from July 7-12 in Nashville, Tennessee.
Henry Schein (Nasdaq: HSIC), the global leader in healthcare solutions for dental and medical practitioners, announced its upcoming presentations at key investor conferences in June 2024. The company will present at the Jefferies Global Healthcare Conference in New York on June 5 at 10:00 a.m. Eastern time and the Goldman Sachs Global Healthcare Conference in Miami on June 11 at 11:20 a.m. Eastern time.
These presentations will be accessible via live webcast, with replays available post-event on the Henry Schein website.
Henry Schein (Nasdaq: HSIC) commits over $200,000 in cash and healthcare product donations to support recovery efforts in Brazil after severe flooding. Both the company and the Henry Schein Cares Foundation (HSCF) will match employee contributions to the 2024 Relief Fund, which aims to help those affected by the disaster. The initiative includes donations of essential healthcare supplies to partner relief organizations. Henry Schein's engagement with Brazil's dental sector since 2014 involves companies like Dental Cremer, Simples Dental, and S.I.N. Implant System. Customers impacted by the floods can seek assistance through local customer service channels.
Henry Schein, Inc. extends its partnership with Special Olympics through 2025, supporting health screenings and education for athletes with intellectual disabilities worldwide. The company donates oral health and medical care products for the Healthy Athletes program at select events across five countries. This collaboration aims to promote the physical and social-emotional well-being of individuals with intellectual disabilities, reducing health disparities and increasing life expectancy. Henry Schein's contributions have benefitted Special Olympics athletes since 2018, with recent support during the June 2023 Special Olympics World Games in Berlin, Germany. The partnership encourages health care providers to volunteer their services and enhance care practices for individuals with intellectual disabilities.
Henry Schein, Inc. reported solid first-quarter 2024 financial results with sales growth of 3.7%, GAAP diluted EPS of $0.72, and non-GAAP diluted EPS of $1.10. The company tightened its total sales growth guidance range to 8% to 10% and affirmed its 2024 non-GAAP diluted EPS guidance of $5.00 to $5.16. Adjusted EBITDA growth is expected to be more than 15% in 2024.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
